Clinical Trial Update: Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome [NA]

View source ↗

Summary

Gelsectan is being evaluated in a clinical trial for diarrhea-predominant irritable bowel syndrome. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Gelsectan

Snippet

Sponsor: Devintec Sagl | Conditions: Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D) | NA | Status: RECRUITING